{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910967544703321"]
[null,null,"Titolo",null,"E. coli infections : causes, treatment and prevention / / Morgan C. Rogers and Nancy D. Peterson, editors"]
[null,null,"Pubbl/distr/stampa",null,"Hauppauge, N.Y., : Nova Science Publishers Inc., 2011"]
[null,null,"ISBN",null,"1-61324-739-7"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (270 p.)"]
[null,null,"Collana",null,"Bacteriology research developments"]
[null,null,"Disciplina",null,"579.3/42"]
[null,null,"Soggetti",null,"Escherichia coli infections"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Uropathogenic escherichia coli : the pre-eminent urinary tract infection pathogen / David W. Hilbert, Women's Health Research Center, Medical Diagnostic Laboratories, Hamilton, New Jersey, USA -- E. coli Infections in Urology : Causes, Treatment and Prevention / Chelsea N. Elwood, Peter Cadieux, Dirk Lange, The Stone Centre at Vancouver General Hospital, University of British Columbia (UBC), Vancouver, British Columbia, Canada, and others -- Aptamer-Based Detection and Therapeutics to Prevent and Treat E. coli Infections / John G. Bruno, Maria P. Carrillo, Taylor Phillips, Alissa Savage, Joseph R. Koke, Operational Technologies Corporation, San Antonio, Texas, USA, and others -- Lactoferrin : A Novel Natural Host Defense Protein against Escherichia coli Infection / Chih-Ching Yen, Hsiao-Ling Chen, Chuan-Mu Chen, Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan, and others --"]
[{"$nulls":4},"Perinatal Antibiotic Use and Antimicrobial Resistance : Examining Escherichia coli as a Model / Nevio Cimolai, Program of Microbiology, Virology, and Infection Control, Children's and Women's Health Centre of British Columbia, Vancouver, British Columbia, Canada, and others -- Implication of Enterotoxigenic Escherichia coli Pathogenicity from the Human Perspective / Iram Liaqat, University of Western Australia -- Prevention of E. coli Infections using Organic Acids / Eva Skrivanová, Milan Marounek, Institute of Animal Science, Department of Physiology of Nutrition and Quality of Animal Products, Prátelství, Prague, Czech Republic -- Current Status on the Etiology, Epidemiology, Food Safety Implications and Control Measures in Escherichia coli 0157:H7 Infections / G. Normanno, Department of Health and Animal Welfare, Faculty of Veterinary Medicine, Valenzano (Ba), Italy -- Maillard "]
[{"$nulls":4},"Reaction and Spontaneous Mutagenesis in Escherichia coli / Roumyana Mironova, Yordan Handzhiyski, Toshimitsu Niwa, Alfredo Berzal-Herranz, Kirill A. Datsenko, Barry L. Wanner, Ivan Ivanov, Department of Gene Regulations, Institute of Molecular Biology, Bulgarian Academy of Sciences, Sofia, Bulgaria, and others."]
[null,null,null,"Sommario/riassunto","Presents research in the study of E coli infections, including urinary tract infections caused by E coli; aptamer-based detection and therapeutics to prevent and treat E coli infections; Lactoferrin as a novel natural host defence protein; enterotoxigenic escherichia coli colonisation factors; and, the prevention of E coli using organic acids."]